Can prednisolone cause yeast infection
Pro Research Analysisby 
Searched over 200M research papers
Prednisolone and Yeast Infections: Analyzing the Risks
Prednisolone and Increased Susceptibility to Infections
Prednisolone, a corticosteroid commonly used to treat various inflammatory and autoimmune conditions, has been shown to increase susceptibility to infections. This is particularly evident in patients with severe alcoholic hepatitis (SAH), where prednisolone treatment has been associated with a higher incidence of serious infections. A study involving 1092 patients revealed that those treated with prednisolone had a significantly higher risk of developing serious infections compared to those who did not receive the drug . This increased risk of infection can lead to higher mortality rates, emphasizing the need for careful monitoring and management of patients on prednisolone therapy.
Prednisolone and Yeast Infections in Specific Conditions
Experimental Candida Infections in Dairy Cattle
In an experimental study on dairy cattle, the growth of Candida krusei in mammary glands treated with a combination of penicillin, dihydrostreptomycin, and prednisolone was compared to untreated glands. The results indicated that while the number of leukocytes increased during treatment, the number of yeast organisms isolated remained the same or decreased, suggesting that prednisolone did not significantly promote yeast growth in this context .
Immunosuppressive Therapy and Yeast Contamination
Patients with kidney diseases receiving immunosuppressive therapy, including prednisolone, showed increased contamination with yeast-like fungi and a higher incidence of candidiasis. This was more pronounced when prednisolone was combined with azathioprine, compared to cyclophosphamide. The study highlighted the need for antifungal prophylaxis and careful monitoring of yeast infections in patients undergoing such treatments .
Case of Fulminant Candidemia
A case report described a 77-year-old man treated with prednisolone for pemphigus who developed severe sepsis and candidemia. Despite prompt antifungal treatment, the patient did not recover, and autopsy revealed widespread yeast infection. This case underscores the potential severity of yeast infections in patients on prednisolone, particularly when combined with other immunosuppressive agents .
Combined Treatments and Yeast Infections
Corticosteroids and Antifungal Therapy
In a study on experimental Candida albicans keratitis in rabbits, the combination of fluconazole and prednisolone was evaluated. The results suggested that delayed administration of high-dose prednisolone after initial antifungal treatment did not significantly increase the recultivation rate of C. albicans, indicating that corticosteroids might be safely used in conjunction with antifungal therapy if timed appropriately .
Conclusion
Prednisolone can indeed increase the risk of yeast infections, particularly in patients with compromised immune systems or those receiving combined immunosuppressive therapies. While some studies suggest that prednisolone does not significantly promote yeast growth in certain experimental conditions, clinical evidence points to a heightened risk of serious infections, including candidiasis, in patients treated with this corticosteroid. Careful monitoring and appropriate antifungal prophylaxis are essential to mitigate these risks.
Sources and full results
Most relevant research papers on this topic